Steven P. Lee

University of Birmingham — United Kingdom

Medicine · Health Sciences

30h-index2.9kcitations105works27.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral-associated cancers and disorders(25), Immune Cell Function and Interaction(25), War, Ethics, and Justification(21), Global Peace and Security Dynamics(17), CAR-T cell therapy research(15)

Publications105 total

Targeting the activated microenvironment with endosialin (CD248)-directed CAR-T cells ablates perivascular cells to impair tumor growth and metastasis
Journal for ImmunoTherapy of Cancer·2024· 27 citedOpen Access
Data from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure S1 from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure S2 from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure S3 from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure S3 from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure S2 from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Data from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure S1 from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Data from Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer
2023Open Access
Supplementary Data from Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer
2023Open Access
Supplementary Data from Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer
2023Open Access
Data from Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer
2023Open Access
Guiding principles for culturally responsive facilitation: Lessons learned from delivering culturally aware mentor training to STEMM faculty.
Journal of Diversity in Higher Education·2023· 11 citedOpen Access
Reassess–Realign–Reimagine: A Guide for Mentors Pivoting to Remote Research Mentoring
CBE—Life Sciences Education·2021· 19 citedOpen Access
CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth
JCI Insight·2020· 66 citedOpen Access
An evaluation of the tumour endothelial marker <scp>CLEC14A</scp> as a therapeutic target in solid tumours
The Journal of Pathology Clinical Research·2020· 15 citedOpen Access
Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity
Blood·2020· 164 citedOpen Access
Democracy and Populism
AMINTAPHIL·2020· 2 cited
TEM8/ANTXR1-specific CAR T cells mediate toxicity in vivo
PLoS ONE·2019· 38 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Alan B. Rickinson(10), Wendy A. Thomas(6), Neil Blake(4), Anthony T.�C. Chan(4), Elizabeth Jinks(4), Joseph Robinson(4), Katharine Whitworth(4), Jill Brooks(3), Baksho Kaul(3), Debbie Croom-Carter(3), J Crocker(3), Greg Parsonage(3), Heather M. Long(3), Martin Rowe(3), Lee R. Machado(3), Peter F. Searle(3), Vanessa Tubb(2), Tracey A. Haigh(2), Graham S. Taylor(2), Philip J. Johnson(2)